Webinar

CM-PRISM is the new Common Metrics data reporting software platform developed specifically for the CTSA Program hubs to enter their annual data and narratives. The new software platform is built in REDCap, which is familiar to many hubs and was chosen based on its flexibility to accommodate multiple users, provide continued growth as metrics evolve, and ease of data entry. CLIC has scheduled two

CM-PRISM is the new Common Metrics data reporting software platform developed specifically for the CTSA Program hubs to enter their annual data and narratives. The new software platform is built in REDCap, which is familiar to many hubs and was chosen based on its flexibility to accommodate multiple users, provide continued growth as metrics evolve, and ease of data entry. CLIC has scheduled two

Sjӧgren's syndrome (SS), the second most common rheumatic disease contributing nine times the cost of a healthy person, has hallmark features of oral and ocular dryness due to salivary and lacrimal gland inflammation. Minor salivary glands, central to the pathogenesis and diagnosis of SS, contain mesenchymal stromal cells (MSCs). In other conditions MSCs are responsible for tissue repair and

The Foundations of Biomedical Data Science virtual seminar series is an exciting and topical set of regularly scheduled, weekly, webinar presentations covering the basics of data management, representation, computation, statistical inference, data modeling, & other topics relevant to “big data” biomedicine. The seminar series provides fundamental topic introductions suitable for individuals at all

Dr. Petzinger's work focuses on understanding how to promote brain repair after injury, particularly in the context of Parkinson's disease. The focus of this talk will be to review mechanisms of exercise induced neuroplasticity in a rodent model of Parkinson's disease and to examine exercise effects on cognition and motor performance in Parkinson's disease. Speaker Bio: Dr. Giselle Petzinger is an

Please register in advance here: https://bit.ly/3pUUU8q All are welcome to virtually attend; please share this announcement widely! Abstract: Funding opportunities for Research on Evaluation (RoE) often appear to be few and far between. However, the Faster Forward Fund (3F) is one example that offers hope to RoE die-hards that funding opportunities do indeed exist! Started by Michael Scriven, 3F

You are invited to join us on January 8th, 2021, 9am Pacific/12pm Eastern, for the first online presentation of 2021 in the Foundations of Biomedical Data Science Seminar Series! Our featured speakers will be Dr. Karen Johnston and Johanna Loomba from University of Virginia discussing "Introduction to Use of Structured Medical Record Data." Abstract: Electronic medical record (EMR) data is encoded

Researchers planning COVID-19 trials with the Trial Innovation Network (TIN) can leverage the N3C to inform their research hypotheses. N3C focuses on aligning its infrastructure so that it can generate efficient and minimally biased results. Part of that infrastructure includes the curation of value sets and phenotype variables relevant to COVID-19, such as ventilator support, ICU use, and

This webinar presents scholarly research conducted by the Tufts Center for the Study of Drug Development, Tufts University School of Medicine examining trends in protocol design practice and their impact on clinical trial performance and quality. In particular, the webinar will explore innovative approaches being used to leverage patient and study volunteer input and experience to modify protocol

The development of health and biological response to treatment varies by age, yet many studies still fail to incorporate the dimension of time into their research. In January 2019 the National Institutes of Health adopted the Inclusion across the Lifespan Policy mandating that “individuals of all ages, including children and older adults, must be included in all human subjects research (45 CFR 46)

Join Stanford Medicine Office of Community Engagement for the 6th Virtual Town Hall on the COVID-19 outbreak, focusing on Vaccine Clinical Trials. Topics will include: How do vaccine clinical trials work? What do we know about the current vaccine trials underway in the United States? How do we know if it’s safe to participate in a trial? Who can/should participate in vaccine trials? Perspectives

Implementing your research project within an Electronic Health Record (EHR) system is an exciting but complex endeavor that requires specialized tools and approaches. This talk will unpack what dedicated teams of informaticians have pioneered over the past decade. It will help the researcher understand a path forward for their research protocols. The talk addresses key differences between

The NIA staff will discuss some of the limitations with inclusion of diverse populations observed in clinical research and trials, the role federal science policy is playing in remedying the limitations and promoting more broad and consistent inclusion of communities of color in developing new strategies implemented to enhance inclusion among older persons of color. The NIA team will provide an

FREE Webinar Thursday, October 29, 2020 11:00 am – 12:00 pm Eastern (US) Registration for the webinar is not required. Add to calendar Join Critical Path Institute’s Electronic Patient-Reported Outcome (ePRO) Consortium and Patient-Reported Outcome (PRO) Consortium for a free 1-hour webinar to discuss how the collection of ePRO data in clinical trials has been impacted by COVID-19. Hear from

Talk 1 Title: Evaluating biomarkers using right accuracy measures: a statistician’s perspective Presenter: Lili Tian, Ph.D. Professor, Associate chair, and Director of graduate studies Department of Biostatistics SUNY at Buffalo Talk 2 Title: Inferring mutation order in cancer using a phylogenetic approach Presenter: Laura Kubatko, PhD Professor and Co-Director, Mathematical Biosciences Institute

What is emotionally challenging research? How does recognizing your emotions during research lead to more ethical and methodologically sound practices? If you are interested in learning more, please join us for this brief 30-minute webinar. During this session, the presenters will provide an overview of the newly released CONVERGE Conducting Emotionally Challenging Research Training Module. The

Community members & community health experts, academic faculty & researchers across the CTSA are invited to attend this special webinar via Zoom: "Bridging Digital Research and Community/Patient Engagement Strategies to Advance a Healthy Georgia" Overarching Purpose: To leverage academic-community partnered strategies that will contribute to the nationally recognized impetus to link geographically

There is a growing interest in transparency, openness, and reproducibility as mechanisms to advance the credibility and utility of the scientific enterprise. This webinar will introduce open science to a clinical and translational research audience. It will begin by introducing the opportunities and challenges motivating the wider open science movement, such as accelerating scientific discovery

In this 60-minute webinar, Dr. Tenaerts presents the work of the Clinical Trials Transformation Initiative (CTTI) and discusses two main topics regarding digital clinical trials: (1) moving ongoing trials to remote and (2) planning for decentralized trials. At the conclusion of this webinar you will be able to • Recognize how the trials community has pivoted to virtual and remote visits for

This webinar will provide an updated overview of Trials Today – an online tool that helps potential participants find studies that are of interest to them and their health condition. Trials Today is a quick and easy way to search the thousands of studies in ClinicalTrials.gov that are recruiting participants.

UNC Health Investigational Drug Services (IDS) has released detailed Standard Operating Procedures (SOPs) to facilitate the standardization of practice and streamlining processes. The SOPs are intended to clarify practices and procedures of IDS so that they are communicating as clearly as possible with clinical trials partners at UNC. In keeping with this goal of clear communication, UNC IDS is

The required use of single IRB review for most federally funded research has had a significant impact on human research protection programs. More institutions cede IRB review than serve as Reviewing IRBs. Panelists for this SMART Talk will explore the effects on institutions of relying on external IRBs, what processes institutions should have in place to oversee their research portfolios even when

During this session, participants will learn about the field of translational science, how NCATS is developing this new field of investigation and opportunities to conduct translational science research in the NCATS intramural (i.e., on-site in Maryland) laboratories. NCATS defines translational science as “an emerging field of investigation focused on identifying and understanding broadly

Panelists will discuss differences that arise between Reviewing IRBs and Relying Institutions surrounding pediatric research, such as assent process, age of assent, pregnancy testing, risk assessment, and state laws. Hear experts talk about their experiences, how they work with institutions to address disagreements, and potential areas for flexibility and harmonization Speakers: Lori Roesch, Human

In this webinar, Dr. Alexey Nesvizhskii, will demonstrate his ultrafast MSFragger software. Dr. Nesvizhskii created the MSFragger database search tool in 2017 to comprehensively identify peptides and their modified forms in mass spectrometry-based proteomics. Due to its ultrafast processing speed, MSFragger can quickly perform open searches for data sets containing millions of mass spectrometry

The purpose of this panel is to demonstrate the application of current qualitative methods to evaluate clinical and translational science programs, organizations, and enterprises. Time will be distributed evenly to the five presenters, who will speak for 8 minutes and allow for 4-5 minutes of Q & A. The five presenters and their topics are as follows: Clara Pelfrey(Case Western Reserve University)